Ablating the Rab‐GTPase activating protein TBC1D1 predisposes rats to high‐fat diet‐induced cardiomyopathy. (4th February 2020)

• Record Type: Journal Article
• Authors: Barbeau, Pierre‐Andre; Houad, Jacy M.; Huber, Jason S.; Paglialunga, Sabina; Snook, Laelie A.; Herbst, Eric A. F.; Dennis, Kaitlyn M. J. H.; Simpson, Jeremy A.; Holloway, Graham P.
• Is Part Of: Journal of physiology. Volume 598:Number 4(2020)
• Page Start: 683
• Page End: 697
• Publication Date: 2020-02-04
• Subjects: cardiac tissue metabolism -- carbohydrate metabolism -- fatty acid metabolism -- GTPase‐activating protein (GAP) -- plasma membrane fatty acid binding protein (FABPpm) -- TBC1D1; Physiology -- Periodicals; 612.005
• DOI: 10.1113/JP279042
• Languages: English
• ISSNs: 0022-3751

Abstract

Abstract : Key points: Although the role of TBC1D1 within the heart remains unknown, expression of TBC1D1 increases in the left ventricle following an acute infarction, suggesting a biological importance within this tissue. We investigated the mechanistic role of TBC1D1 within the heart, aiming to establish the consequences of attenuating TBC1D1 signalling in the development of diabetic cardiomyopathy, as well as to determine potential sex differences. TBC1D1 ablation increased plasma membrane fatty acid binding protein content and myocardial palmitate oxidation. Following high‐fat feeding, TBC1D1 ablation dramatically increased fibrosis and induced end‐diastolic dysfunction in both male and female rats in the absence of changes in mitochondrial bioenergetics. Altogether, independent of sex, ablating TBC1D1 predisposes the left ventricle to pathological remodelling following high‐fat feeding, and suggests TBC1D1 protects against diabetic cardiomyopathy. Abstract: TBC1D1, a Rab‐GTPase activating protein, is involved in the regulation of glucose handling and substrate metabolism within skeletal muscle, and is essential for maintaining pancreatic β‐cell mass and insulin secretion. However, the function of TBC1D1 within the heart is largely unknown. Therefore, we examined the role of TBC1D1 in the left ventricle and the functional consequence of ablating TBC1D1 on the susceptibility to high‐fat diet‐induced abnormalities. Since mutations within TBC1D1 (R125W) display stronger associations with clinical parameters in women, we further examined possible sex differences in the predisposition to diabetic cardiomyopathy. In control‐fed animals, TBC1D1 ablation did not alter insulin‐stimulated glucose uptake, or echocardiogram parameters, but increased accumulation of a plasma membrane fatty acid transporter and the capacity for palmitate oxidation. When challenged with an 8 week high‐fat diet, TBC1D1 knockout rats displayed a four‐fold increase in fibrosis compared to wild‐type animals, and this was associated with diastolic dysfunction, suggesting a predisposition to diet‐induced cardiomyopathy. Interestingly, high‐fat feeding only induced cardiac hypertrophy in male TBC1D1 knockout animals, implicating a possible sex difference. Mitochondrial respiratory capacity and substrate sensitivity to pyruvate and ADP were not altered by diet or TBC1D1 ablation, nor were markers of oxidative stress, or indices of overt heart failure. Altogether, independent of sex, ablation of TBC1D1 not only increased the susceptibility to high‐fat diet‐induced diastolic dysfunction and left ventricular fibrosis, independent of sex, but also predisposed male animals to the development of cardiac hypertrophy. These data suggest that TBC1D1 may exert cardioprotective effects in the development of diabetic cardiomyopathy. Key points: Although the role of TBC1D1 within the heart remains unknown, expression of TBC1D1 increases in the left ventricle following an acute infarction, suggesting a biological importance within this tissue. We investigated the mechanistic role of TBC1D1 within the heart, aiming to establish the consequences of attenuating TBC1D1 signalling in the development of diabetic cardiomyopathy, as well as to determine potential sex differences. TBC1D1 ablation increased plasma membrane fatty acid binding protein content and myocardial palmitate oxidation. Following high‐fat feeding, TBC1D1 ablation dramatically increased fibrosis and induced end‐diastolic dysfunction in both male and female rats in the absence of changes in mitochondrial bioenergetics. Altogether, independent of sex, ablating TBC1D1 predisposes the left ventricle to pathological remodelling following high‐fat feeding, and suggests TBC1D1 protects against diabetic cardiomyopathy.